…
Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Oaktree Specialty Lending Corp is a closed-end business development company that provides secured loans and other debt to U.S. middle-market companies and is externally managed by Oaktree Capital. Long-term growth may be supported by income from senior-secured and floating-rate credit, diversification across issuers, and access to Oaktree's deal flow; investors may find the company attractive for its yield-oriented, defensive credit focus.
Key risks include credit losses and limited liquidity in private loan portfolios, leverage that can amplify downturns, and reliance on market conditions and manager execution which could pressure dividends.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Income before tax | 119.06M | 32.86M | 240.84M | 37.45M | 127.17M |
| Net income | 117.33M | 29.22M | 237.26M | 39.22M | 126.16M |
| Selling general administrative | 11.66M | 9.25M | 9.07M | 7.12M | 7.95M |
| Gross profit | 125.20M | 39.11M | 248.31M | 52.31M | 127.13M |
| Ebit | 180.78M | 79.79M | 240.84M | 37.45M | 127.17M |
| Ebitda | 180.78M | 216.04M | 126.32M | 37.45M | 127.17M |
| Depreciation and amortization | -292.34M | 136.25M | -114.52M | -98.28M | -100.33M |
| Operating income | 180.78M | 79.79M | 240.84M | 37.45M | 127.17M |
| Other operating expenses | 9.77M | 6.25M | 7.46M | 14.86M | 0.04M |
| Interest expense | 111.64M | 46.93M | 30.52M | 26.29M | 32.43M |
| Tax provision | 1.73M | 3.64M | 2.79M | -1.77M | 1.01M |
| Interest income | 368.53M | 249.44M | 190.83M | 133.43M | 139.17M |
| Net interest income | 256.89M | 202.51M | 160.31M | 107.14M | 106.74M |
| Income tax expense | 1.73M | 3.64M | 3.58M | -1.77M | 1.01M |
| Total revenue | 125.20M | 39.11M | 248.31M | 52.31M | 127.13M |
| Total operating expenses | 6.14M | 6.25M | 7.46M | 14.86M | -0.04M |
| Cost of revenue | -223.56M | 55.66M | 71.40M | 39.26M | 50.32M |
| Total other income expense net | -61.71M | -46.93M | -30.52M | -26.29M | -32.43M |
| Net income from continuing ops | 117.33M | 29.22M | 237.26M | 39.22M | 126.16M |
| Net income applicable to common shares | - | 29.22M | 237.26M | 39.22M | 126.16M |
| Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Total assets | 3217.84M | 2646.31M | 2636.39M | 1640.71M | 1481.04M |
| Other current assets | - | 9.62M | -29.33M | 0.22M | 0.49M |
| Total liab | 1702.08M | 1400.75M | 1323.56M | 725.83M | 550.41M |
| Total stockholder equity | 1515.76M | 1245.56M | 1312.82M | 914.88M | 930.63M |
| Deferred long term liab | - | 7.38M | 9.31M | 6.01M | 6.40M |
| Other current liab | -18.96M | -11.64M | -7.62M | -2.70M | -3.88M |
| Common stock | 0.77M | 1.83M | 1.80M | 1.41M | 1.41M |
| Capital stock | 0.77M | 1.83M | 1.80M | 1.41M | 1.41M |
| Retained earnings | -651.34M | -582.77M | -493.33M | -574.30M | -558.55M |
| Other liab | - | - | 2.11M | - | 0.70M |
| Other assets | 139.49M | 13.57M | 14.61M | 8.76M | 8.73M |
| Cash | 136.45M | 23.53M | 29.33M | 39.10M | 15.41M |
| Total current liabilities | 18.96M | 11.64M | 7.62M | 2.70M | 3.88M |
| Net debt | 1464.28M | 1277.52M | 1239.41M | 670.22M | 457.96M |
| Short term debt | - | 601.04M | 638.74M | - | - |
| Short long term debt total | 1600.73M | 1301.04M | 1268.74M | 709.32M | 473.37M |
| Other stockholder equity | 2166.33M | 1826.50M | 1804.35M | 1487.77M | 1487.77M |
| Total current assets | 181.02M | 131.84M | 63.24M | 57.88M | 33.77M |
| Long term investments | 2897.33M | 2500.90M | 2558.54M | 1574.07M | 1438.53M |
| Net tangible assets | - | 1245.56M | 1312.82M | 914.88M | 930.63M |
| Short term investments | -4.91M | 214.16M | - | - | - |
| Net receivables | 160.59M | 108.31M | 33.91M | 18.78M | 18.37M |
| Long term debt | - | - | - | - | 158.54M |
| Accounts payable | 18.96M | 11.64M | 7.62M | 2.70M | 3.88M |
| Common stock total equity | - | - | - | 1.41M | 1.41M |
| Non currrent assets other | -2897.33M | -1.69M | -0.71M | -0.85M | -1438.53M |
| Non current assets total | 2897.33M | 2500.90M | 2558.54M | 1574.07M | 1438.53M |
| Long term debt total | - | - | - | - | 158.54M |
| Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Change to liabilities | - | 0.68M | -0.43M | -0.52M | -1.99M |
| Net borrowings | - | 70.00M | 315.10M | 236.21M | -157.66M |
| Total cash from financing activities | -110.41M | -26.82M | 224.19M | 176.33M | -214.11M |
| Change to operating activities | - | -55.97M | 30.12M | -63.51M | 44.13M |
| Net income | 117.33M | 29.22M | 237.26M | 39.22M | 126.16M |
| Change in cash | 119.17M | -5.27M | -7.46M | 23.69M | 1.92M |
| Begin period cash flow | 26.36M | 31.64M | 39.10M | 15.41M | 13.49M |
| End period cash flow | 145.54M | 26.36M | 31.64M | 39.10M | 15.41M |
| Total cash from operating activities | 228.76M | 22.39M | -230.52M | -152.88M | 215.82M |
| Issuance of capital stock | 1.37M | 20.84M | 0.00M | 0.00M | - |
| Depreciation | 28.55M | 136.25M | -114.52M | 20.61M | -38.46M |
| Dividends paid | 180.05M | 115.25M | 79.85M | 53.10M | 52.22M |
| Change to inventory | -73.52M | 33.16M | 4.62M | 0.41M | -21.28M |
| Change to account receivables | -33.88M | -16.11M | -8.49M | 4.23M | 21.28M |
| Sale purchase of stock | -2.42M | -1.86M | -2.17M | -1.88M | -1.34M |
| Other cashflows from financing activities | 857.68M | 299.45M | 842.96M | 576.68M | 294.60M |
| Change to netincome | - | 60.16M | -493.71M | -134.79M | 45.84M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | -107.40M | -71.41M | 21.20M | -59.80M | 41.24M |
| Stock based compensation | 53.12M | - | 114.39M | -19.06M | 38.17M |
| Other non cash items | 135.49M | -70.69M | -488.98M | -132.30M | 48.42M |
| Free cash flow | 228.76M | 22.39M | -230.52M | -152.88M | 215.82M |
Sector: Financial Services Industry: Credit Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| OCSL Oaktree Specialty Lending Corp |
- -% |
12.03 | 14.14 | 10.26 | 3.82 | 1.01 |
| V Visa Inc. Class A |
-1.56 0.37% |
424.90 | 31.25 | 25.97 | 16.18 | 13.64 |
| MA Mastercard Inc |
-12.51 1.89% |
649.20 | 31.59 | 24.88 | 14.31 | 89.68 |
| AXP American Express Company |
-0.06 0.02% |
318.99 | 21.46 | 18.83 | 3.38 | 6.76 |
| COF Capital One Financial Corporation |
-0.40 0.21% |
192.82 | 11.39 | 8.75 | 2.64 | 1.11 |
Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.
333 South Grand Avenue, Los Angeles, CA, United States, 90071
213 830 6300
| Name | Title | Year Born |
|---|---|---|
| Mr. Armen Panossian J.D. | CEO & Chief Investment Officer | 1977 |
| Mr. Mathew M. Pendo | Pres | 1964 |
| Mr. Aman Kumar | Managing Director & Co-Portfolio Mang. of Life Sciences Direct Lending | NA |
| Mr. Raghav Khanna | Managing Director & Co-Portfolio Mang. | 1984 |
| Mr. Chris McKown | MD, CFO & Treasurer | 1982 |
| Mr. Matthew Stewart C.F.A., CPA, CFA, CPA | Sr. VP & COO | 1985 |
| Mr. Emil O. Caliboso | Accounting Supervisor | NA |
| Mr. Michael Mosticchio | Investor Relations | NA |
| Ms. Ashley Pak | Chief Compliance Officer | 1978 |
| Mr. Sandeep Kumar Khorana | Managing Director of Origination | 1973 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.